NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 14 filers reported holding NOVUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $53,000 | – | 10,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 90,199 | $421,000 | 0.26% |
| Boxer Capital, LLC | 324,383 | $1,515,000 | 0.17% |
| Orbimed Advisors | 2,537,110 | $11,848,000 | 0.14% |
| RTW INVESTMENTS, LP | 316,257 | $1,477,000 | 0.09% |
| B. Riley Wealth Advisors, Inc. | 45,000 | $211,000 | 0.02% |
| Sequoia Financial Advisors, LLC | 17,500 | $82,000 | 0.01% |
| Renaissance Technologies | 251,556 | $1,175,000 | 0.00% |
| VANGUARD GROUP INC | 135,599 | $633,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 12,499 | $58,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 10,944 | $51,000 | 0.00% |